Clinical Study

Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection

Table 1

Baseline characteristics of patients.

Characteristics( )

Age (years)
Sex (M/F)12/12
Past treatment (Yes/No)15/9
Body weight (kg)
Ribavirin (mg/kg/day)
Hemoglobin (g/dL)
HCV RNA (KIU/mL)
1001
 100 5003
 500 8504
 850 16

Data are expressed as mean S.D. or number of patients
HCV: Hepatitis C virus.